ZD1839 (Gefitinib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ZD1839 (Gefitinib), covering 2012-04-17 to 2012-04-17. Get the full timeline:
Most recent: Clinical Trial Update: ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors [Phase 1]